Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To develop and validate a deep learning (DL)‐based radiomics model to predict the response to chemotherapy in colorectal liver metastases (CRLM).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>In this retrospective study, we enrolled 192 patients diagnosed with CRLM who received first‐line chemotherapy and were followed by response assessment. Tumor response was identified according to the Response Evaluation Criteria in Solid Tumors (RECIST). Contrast‐enhanced multidetector computed tomography (MDCT) images were fed as inputs of the ResNet10‐based DL radiomics model, and the possibility of response was predicted as the output. The final combined DL radiomics model was constructed by integrating the response related clinical factors and the developed DL radiomics signature. A time‐independent validation cohort (n=48) was extracted from the 192 patients to evaluate the DL model with area under the receiver operating characteristic curve (AUC), specificity, and sensitivity. Meanwhile, a traditional radiomics model was constructed using least absolute shrinkage and selection operator (lasso) as comparisons with the DL‐based model.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>According to RECIST criteria, 131 patients were identified as responders with complete response, partial response and stable disease, while 61 patients were non‐responders with progression disease. The selected predictive clinical factor turned out to be the carcinoembryonic antigen (CEA) level with AUC of 0.489 (95% confidence interval [CI], 0.380‐0.599) and 0.558 (95% CI, 0.374‐0.741) in the training and validation cohorts, respectively. The DL‐based model provided better performance than the traditional classifier‐based radiomics model with significantly higher AUC (training: 0.903 [95% CI, 0.851‐0.955] vs.0.745 [95% CI, 0.659‐0.831]; validation: 0.820 [95% CI, 0.681‐0.959] vs. 0.598 [95% CI, 0.422‐0.774]). The combination of DL‐based model with the CEA level provided slightly increased performance with AUC of 0.935 [95% CI, 0.897‐0.973] in the training cohort and 0.830 [95% CI, 0.688‐0.973] in the validation cohort.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The developed DL‐based radiomics model could improve the efficiency to predict the response to chemotherapy in CRLM, which may assist in subsequent personalized treatment decision‐making in CRLM management.</p></section>

Deep Learning Radiomics Model of Contrast-Enhanced CT for Differentiating the Primary Source of Liver Metastases

Deep Learning Radiomics for Focal Liver Lesions Diagnosis on Long-Range Contrast-Enhanced Ultrasound and Clinical Factors

Deep Learning for Accurate Diagnosis of Liver Tumor Based on Magnetic Resonance Imaging and Clinical Data

Deep Learning-Assisted Diagnosis of Liver Tumors Using Non-Contrast Magnetic Resonance Imaging: A Multi-Center Study

Deep Learning Radiomics Model of Dynamic Contrast-Enhanced MRI for Evaluating Vessels Encapsulating Tumor Clusters and Prognosis in Hepatocellular Carcinoma

A Combined Model Integrating Radiomics and Deep Learning Based on Multiparametric Magnetic Resonance Imaging for Classification of Brain Metastases.

Deep learning for predicting the human epidermal growth factor receptor 2 status of breast cancer liver metastases based on contrast-enhanced computed tomography: a development and validation study

A 18F-FDG PET/CT-based Deep Learning-Radiomics-clinical Model for Prediction of Cervical Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma

Radiomics-based Automated Machine Learning for Differentiating Focal Liver Lesions on Unenhanced Computed Tomography

Novel Deep Learning Radiomics Model for Preoperative Evaluation of Hepatocellular Carcinoma Differentiation Based on Computed Tomography Data

Deep learning‐based radiomics predicts response to chemotherapy in colorectal liver metastases

Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR images

A deep learning model based on contrast-enhanced computed tomography for differential diagnosis of gallbladder carcinoma

Tumor classification of gastrointestinal liver metastases using CT-based radiomics and deep learning

Differentiation of Lung Metastases Originated From Different Primary Tumors Using Radiomics Features Based on CT Imaging

CT-based intratumoral and peritumoral deep transfer learning features prediction of lymph node metastasis in non-small cell lung cancer

Assessment of Primary Colorectal Cancer CT Radiomics to Predict Metachronous Liver Metastasis

Development and Validation of Multiparametric MRI-based Interpretable Deep Learning Radiomics Fusion Model for Predicting Lymph Node Metastasis and Prognosis in Rectal Cancer: A Two-center Study

A comparative study between deep learning and radiomics models in grading liver tumors using hepatobiliary phase contrast-enhanced MR images

Value of CT-Based Radiomics in Predicating the Efficacy of Anti-HER2 Therapy for Patients With Liver Metastases From Breast Cancer